Don't Fear the Big Yield. Test What Covers It.

A 6% dividend yield looks like a confession. For Energy Transfer it does not: the pipeline operator yields above 6%, yet its second-quarter distributable cash flow of $2.59 billion was roughly double the $1.17 billion it paid out to unitholders for the quarter, and it raised the distribution for a nineteenth consecutive quarter. The yield got big because the stock spent years down, not because the payout failed. A scary percentage is not the same thing as a slash in progress.

The trap is reading the yield as evidence. A yield is just the dividend divided by the price, so it climbs whenever the share falls — which is exactly what happens when the market starts doubting the payout. The percentage is the market's estimate of how much risk already sits in that income stream. The question is whether the doubt is justified, and the only honest way to answer it is by counting cash.

That is where the number everyone quotes, the payout ratio, does real damage. The version on most screens is the dividend divided by reported net income. But net income can sit far below the cash a company actually keeps, because it includes large non-cash charges — write-downs that hurt the accounting statement and touch no wallet. Two of the market's most-feared big yields are exactly this case in reverse.

Kraft Heinz and Pfizer: the ratio screams, the cash is quiet

Kraft Heinz yields about 6.5%, and its screen looks like a cut is inevitable: the company posted a $5.46 billion net loss in the second quarter, driven mainly by multi-billion-dollar goodwill and intangible-asset impairments. Divide the dividend into that loss and you get a meaningless negative number. Against free cash flow, the picture flips. Kraft generated about $3.8 billion of free cash flow over the trailing year against roughly $1.9 billion of dividends it paid. The current check is funded. The 6.5% yield is not pricing an insolvent payout; it is pricing a slow bleed — a portfolio of food brands losing share to cheaper rivals. Cash covers the dividend today. The doubt is what those brands earn ten years from now.

Pfizer runs the same pattern with a thinner cushion. Its yield is about 6.2% and its reported payout ratio tops 130%, straight through the textbook danger line. But that number counts large write-downs from acquisitions that disappointed. On cash, Pfizer generated roughly $11 billion of free cash flow over the trailing year against about $10 billion in dividends — covered, but only just. That margin is the real message. A wave of patent expirations worth $17 billion to $20 billion is building, and if revenue slides faster than a $10 billion dividend can shrink, the padding closes. The yield is the market quoting that specific future, not a statement that today's check bounces.

The one test that actually gets thin

Then there is the case where the test narrows: USA Compression. The gas-compression partnership yields more than 7%, the highest of the group, and its coverage is merely adequate — distributable cash flow covered the distribution about 1.65 times in the second quarter, the distribution has not grown in a year, and the balance sheet carries roughly $2.9 billion of debt against a thin equity base. It is funded today. It is funded with the least margin and the most leverage, which is the structure a downturn in natural-gas volumes would test first. This one belongs on a watchlist, not in a retirement income slot.

None of this means the big-yield warning is empty. A big yield is the market's honest, dollar-weighted guess that the payout is at risk, and for Kraft and Pfizer the risk is real — it is just forward-looking rather than present. A dividend cut, when it comes, happens on future cash flow, not on the current check. So the discipline is to stop treating the yield as a verdict and start asking what covers it: does free cash flow after reinvestment and debt service pay the dividend comfortably, and can that cash flow survive whatever the yield is worried about? Coverage settles the near term. The forward variable — brand share, a patent cliff, leverage against commodity volumes — decides whether the market's fear and the low price that bought it are right. A funded dividend is not a safe dividend. It is only a dividend that cash flow has not abandoned yet.